MIF-1 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
MIF-1 (Pro-Leu-Gly-NH2 (Melanocyte-inhibiting factor-1)) is a Neuropeptide, dopamine receptor modulator researched for antidepressant effects, nootropic enhancement, anti-Parkinsonian action, dopamine modulation. Common dosages range from 1-10 mg administered once daily. Below are the most frequently asked questions.
Frequently Asked Questions About MIF-1
What is MIF-1?
MIF-1 (Pro-Leu-Gly-NH2 (Melanocyte-inhibiting factor-1)) is a Neuropeptide, dopamine receptor modulator. Endogenous tripeptide derived from cleavage of oxytocin, produced primarily by the hypothalamus. It is researched for antidepressant effects, nootropic enhancement, anti-Parkinsonian action, dopamine modulation.
What is the recommended MIF-1 dosage?
Common dosages range from 1-10 mg, administered once daily via subcutaneous injection (poorly active orally). Cycles typically run not established; short protocols in research.
What are the side effects of MIF-1?
Limited human data. Inverted U-curve response — loses efficacy at very high doses. No serious adverse effects documented.
Is MIF-1 legal?
Not FDA-approved. Research chemical.
What is the half-life of MIF-1?
The half-life of MIF-1 is resistant to bloodstream metabolism; crosses blood-brain barrier, which determines the once daily dosing schedule.
How do you reconstitute MIF-1?
Add bacteriostatic water to the lyophilized MIF-1 vial. Let the water run down the side — never spray on the powder. Swirl gently. Use our peptide calculator for exact amounts.
Can you stack MIF-1 with other peptides?
Pairs with dopamine-enhancing compounds (L-DOPA) to amplify dopaminergic effects through allosteric modulation.
Where can you buy MIF-1?
MIF-1 is available as a research chemical from vetted suppliers with third-party COA testing.
How long does it take MIF-1 to work?
Initial effects may be noticed within 1-2 weeks, with more significant results typically appearing by weeks 4-8 of a not established; short protocols in research cycle.
What makes MIF-1 unique?
Unique as an allosteric dopamine modulator rather than agonist — enhances endogenous dopamine signaling without directly activating receptors, a mechanism distinct from most dopaminergic drugs.
Complete Guide
MIF-1 : Benefits, Dosage, Side Effects & Research
Related Reading
- MIF-1 Dosage Guide
- MIF-1 Benefits
- MIF-1 Side Effects
- MIF-1 Stacking Guide
- MIF-1 Cycle Guide
- MIF-1 Research
Calculate Your MIF-1 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MIF-1.
Open Calculator →Research-Grade Sourcing
If you're going to research MIF-1, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is MIF-1?
MIF-1 (Pro-Leu-Gly-NH2 (Melanocyte-inhibiting factor-1)) is a Neuropeptide, dopamine receptor modulator. Endogenous tripeptide derived from cleavage of oxytocin, produced primarily by the hypothalamus. It is researched for antidepressant effects, nootropic enhancement, anti-Parkinsonian action, dopamine modulation.
What is the recommended MIF-1 dosage?
Common dosages: 1-10 mg administered once daily via subcutaneous injection (poorly active orally). Cycle length: not established; short protocols in research. Half-life: resistant to bloodstream metabolism; crosses blood-brain barrier. Use our peptide calculator for exact reconstitution math.
What are the side effects of MIF-1?
Limited human data. Inverted U-curve response — loses efficacy at very high doses. No serious adverse effects documented.
Is MIF-1 safe?
MIF-1 has shown a preliminary safety profile in research. Not FDA-approved. Research chemical. All research should follow appropriate safety protocols.